Naturalantibody S.A.

Other computer programming activities

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2021-03-08
Share capital
136,613.00 PLN
Activity description

Naturalantibody is a company that streamlines antibody discovery using a comprehensive database that integrates antibody data and employs machine learning solutions for predicting developability issues. It offers tools for structural modeling, paratope prediction, and antibody-antigen docking analysis, along with support for library construction and data visualization. Additionally, it provides free cloud and on-premises versions of its platform for users to manage and analyze their antibody-related data.

Registered address
ul. Cyfrowa 6, 71-441 Szczecin, Poland
Branches
  • ul. Podole 60, 30-394 Kraków
Email
Electronic delivery address
AE:PL-13655-44663-IAREE-27

Financials

Revenue history (in k)

Filing timeliness

1 of 5 financial statements was filed late (for 2021, 89 days late). All were audited by a statutory auditor.

  • 202503/07/2026
  • 202401/07/2025
  • 202305/07/2024
  • 202210/07/2023
  • 202112/10/2022
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Top 16%
Top 16%
City · Szczecin584 / 4,611
Top 13%
Voivodeship · Zachodniopomorskie1,529 / 10,451
Top 15%
Country · Poland46,121 / 297,266
Top 16%

Results vs industry

Revenue
This companyUSD 3.14mMedianUSD 133.69kAverageUSD 3.80m
Net profit
This companyUSD 225.24kMedianUSD 3.74kAverageUSD 319.52k
Operating costs
This companyUSD 3.09mMedianUSD 123.25kAverageUSD 3.36m
Assets
This companyUSD 4.27mMedianUSD 85.00kAverageUSD 3.35m

Offer

  • Antibody discovery platform
  • Antibody databases
  • Bioinformatics software
  • Antibody sequence analysis
  • Mutation prediction

Websites

  • naturalantibody.comAI Computational Solutions for Antibody Engineering – NaturalAntibody
    Google Tag Manager

Job offers

The company has its own careers page: naturalantibody.com/careers.

Authorized Representatives

Dawid Szwonder age 35 – President of the Management Board
Michał Krawczyk age 36 – Attorney-in-fact (sole)

Manner of representation

The company shall be represented as follows: a) in the case of a one-person management board, the company shall be represented by the sole member of the management board; b) in the case of a multi-member management board, the company shall be represented by each member of the management board independently; c) in the case of a multi-member management board and the appointment of a Vice-President of the Management Board for financial matters, the company shall be represented by two members of the management board acting jointly, provided that in every case the joint action of the Vice-President of the Management Board for financial matters shall be required.

Supervisory board

Aleksander Roman Rak age 46 – Supervisory Board Member
Arkadiusz Krawczyk age 66 – Supervisory Board Member
Beata Strączyńska-Krawczyk age 64 – Supervisory Board Member
Wojciech Mateusz Pysiewicz age 35 – Supervisory Board Member

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2020-12-10.

  • mBank
    42 1140 1137 0000 4354 8300 1004
  • mBank
    26 1140 1137 0000 4354 8300 1001
  • mBank
    69 1140 1137 0000 4354 8300 1003

Debt

No entries in the National Debtors Register (KRZ).

MSiG notices

Publication dateEvent
May 25, 2023Shareholders' meeting convened
Sep 8, 2022Shareholders' meeting convened

Public aid

18 public aid cases recorded, with a total value of $5,544,696.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation 2023/2831)
–
De minimis aid (in accordance with Commission Regulation 2023/2831)
–
Aid for SME participation in trade fairs
–

European Funds

4 projects co-financed from European Funds recorded, with total EU co-financing of $5,530,711.

ProjectEU co-financing
Strengthening the export potential of NATURALANTIBODY SPÓŁKA AKCYJNA through participation in international events.
$405.9K
Development of a technology for extracting data from scientific literature using large language models to discover therapeutic antibodies
$853.7K
Development of Specitope technology for bioinformatic prediction of B-cell-specific epitopes, enabling the in silico identification of therapeutic antibody candidates
$2.4M

Competitors

Name
Datawalk S.A.
Dotdata Poland sp. z o.o.
Prointegra S.A.
Evidence Prime sp. z o.o.
Diagnostyka Digital Hub sp. z o.o.
Creatoriq Europe sp. z o.o.
Data4cure Poland sp. z o.o.
Algolytics Technologies sp. z o.o.
Palturai sp. z o.o.
Iamip Technology sp. z o.o.

Change history

DateEvent
2025-01-15Address change
2025-01-15Share capital increase
2024-08-07Share capital increase
2023-11-24Share capital increase
2021-10-07Share capital increase

FAQ

Last updated: 2026-09-03